arrow
J

Jilong Yang

department of bone and soft tissue tumors
H指数:32
被引数:3,356

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunotherapy-based salvage therapy in advanced soft tissue sarcoma after first-line chemotherapy: a retrospective single-center analysis with emphasis on undifferentiated pleomorphic sarcoma

基于免疫治疗的软组织肉瘤一线化疗后挽救治疗:一项以未分化多形性肉瘤为重点的回顾性单中心分析

2026-08-280
OA
HLX07, a novel anti-EGFR antibody, for locally advanced and metastatic cutaneous squamous cell carcinoma: an open-label, multicenter, phase II trial

HLX07,一种新型抗EGFR抗体,用于局部晚期和转移性皮肤鳞状细胞癌:一项开放标签、多中心、II期临床试验

2026-08-040
PRE
Response to commentary on “Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: A dosimetric pooled analysis of individual patient data” by Sawada et al

对Sawada等人关于“胸顶部肺癌立体定向体部放射治疗后臂丛神经病:个体患者剂量学数据的合并分析”的评论的回应

2025-10-050
PRE
Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I study

HH2853(一种新型EZH1/2双抑制剂)在难治性实体瘤或非霍奇金淋巴瘤患者中的安全性与有效性:一项I期研究

2025-08-070
OA
Efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone: a multicenter, phase Ib/II study
2024-11-050
OAAI
Landscape of enhancer disruption and functional screen in melanoma cells
2023-10-302
OAAI